描述 |
Budesonide是一种具有强效抗炎活性的糖皮质类固醇。 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
相关类别 |
|
||||||||||||
溶解度 |
体外:
DMSO:215 mg / mL(499.38 mM;需要超声波和加热)
|
||||||||||||
储备液 |
|
||||||||||||
存储 |
|
||||||||||||
运输 |
室温;可能会有所不同 |
||||||||||||
SMILES |
O=C(C=C[C@@]12C)C=C1CC[C@@]([C@]2([H])[C@@H](O)C[C@@]34C)([H])[C@]3([H])C[C@]5([H])[C@@]4(C(CO)=O)OC(CCC)O5 |
||||||||||||
参考文献 |
|
||||||||||||
相关活性 小分子 |
氢化可的松 | 米非司酮 | 皮质酮 | 泼尼松 | 原人参三醇 | 氟替卡松丙酸酯 | 曲安西龙 | 可的松 | AL 082D06 | 糖皮质激素受体激动剂 | Mapracorat | 环索奈德 | 丙酸倍氯米松 | 丙酸氯倍他索 | Cort108297 |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 599.7±50.0 °C at 760 mmHg |
熔点 | 221-232?C (dec.) |
分子式 | C25H34O6 |
分子量 | 430.534 |
闪点 | 201.8±23.6 °C |
精确质量 | 430.235535 |
PSA | 93.06000 |
LogP | 3.14 |
外观性状 | 白色固体 |
蒸汽压 | 0.0±3.9 mmHg at 25°C |
折射率 | 1.592 |
储存条件 | 库房通风低温干燥 |
|
布地奈德毒性英文版
|
个人防护装备 |
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
危害码 (欧洲) |
Xn:Harmful |
风险声明 (欧洲) |
R40 |
安全声明 (欧洲) |
S22-S36 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | TU3723000 |
海关编码 | 29372900 |
海关编码 | 29372900 |
---|
Processing of pharmaceutical materials by electrospraying under reduced pressure. Drug Dev. Ind. Pharm. 41(1) , 116-23, (2014)
Electrospraying was used in drug particle production.The aim of the research was to evaluate the possibilities to produce drug particles with desired pharmaceutical properties by electrospraying. In p…
|
|
In Vitro Assessment of Uptake and Lysosomal Sequestration of Respiratory Drugs in Alveolar Macrophage Cell Line NR8383. Pharm. Res. 32 , 3937-51, (2015)
To assess accumulation and lysosomal sequestration of 9 drugs used in respiratory indications (plus imipramine as positive control) in the alveolar macrophage (AM) cell line NR8383.For all drugs, upta…
|
|
Bsm1 vitamin D receptor polymorphism and calcium homeostasis following bariatric surgery. J. Invest. Surg. 28(1) , 8-17, (2015)
To evaluate the association between the Bsm1 vitamin D receptor polymorphism and the calcium-vitamin D-parathormone axis following bariatric surgery.This cross-sectional study included 86 morbidly obe…
|
|
Budesonide |
Respules |
Spirocort |
Bidien |
2H-Naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(2-hydroxyacetyl)-4a,6a-dimethyl-8-propyl-, (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)- |
Budesonide,(11β,16α)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione |
S-1320 |
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione |
EINECS 257-139-7 |
Budeson |
Micronyl |
Pulmicort |
MFCD00083259 |
ENTOCORT |
Rhinocort |
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one |
2H-naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-, (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)- |
PREFERID |